Henry O Gosebruch's Net Worth
$91.3 Million
Who is Henry O Gosebruch?
Henry O Gosebruch has an estimated net worth of $91.3 Million. This is based on reported shares across multiple companies, which include AbbVie Inc., Neumora Therapeutics, Inc., ACELYRIN, Inc., and Aptinyx Inc..
SEC CIK
Henry O Gosebruch's CIK is 0001659625
Past Insider Trading and Trends
2019 was Henry O Gosebruch's most active year for acquiring shares with 12 total transactions. Henry O Gosebruch's most active month to acquire stocks was the month of January. 2017 was Henry O Gosebruch's most active year for disposing of shares, totalling 37 transactions. Henry O Gosebruch's most active month to dispose stocks was the month of June. 2022 saw Henry O Gosebruch paying a total of $9,212,091.20 for 306,635 shares, this is the most they've acquired in one year. In 2022 Henry O Gosebruch cashed out on 405,996 shares for a total of $45,655,244.02, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AbbVie Inc. (ABBV) Snapshot price: $193.15
EVP, Chief Strategy Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
$104.93 | -$8,407,754.40 | 41.62K |
May 16
| |||
Form 4/A
| -31.85% | -25.00K |
$147.29 | -$3,682,188.65 | 53.5K |
Mar 1
| |||
Form 4
|
—
|
0
|
$104.93 | -$8,407,754.40 | 16.62K |
May 16
| |||
Form 4
| -60.06% | -25.00K |
$147.29 | -$3,682,188.65 | 16.62K |
Mar 1
| |||
Form 4
| -52.04% | -45.16K |
$149.11 | -$6,733,364.17 | 41.62K |
Feb 25 - Mar 1
| |||
Form 4
| +363.79% | 68.07K |
—
|
—
| 86.78K |
Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
| 97.21K |
Sep 7
| |||
Form 4
| -31.91% | -22.83K |
$107.74 | -$2,460,027.42 | 48.71K |
Feb 28
| |||
Form 4
| +257.61% | 51.54K |
—
|
—
| 71.54K |
Feb 18
| |||
Form 4
| -35.36% | -40.00K |
$99.16 | -$3,975,046.00 | 73.11K |
Nov 20
| |||
Form 4
|
—
|
0
|
—
|
—
| 108.51K |
Apr 6
| |||
Form 4
| -24.91% | -26.04K |
$85.42 | -$2,224,165.96 | 78.51K |
Feb 28
| |||
Form 4
| +128.45% | 58.78K |
—
|
—
| 104.54K |
Feb 20
| |||
Form 4
|
—
|
0
|
—
|
—
| 75.76K |
Aug 14
| |||
Form 4
| +65.56% | 30K |
$67.28 | $2,018,385.00 | 75.76K |
Jul 29
| |||
Form 4
| -33.41% | -22.96K |
$79.41 | -$1,822,935.96 | 45.76K |
Feb 28
| |||
Form 4
| +306.53% | 51.81K |
—
|
—
| 68.72K |
Feb 21
| |||
Form 4
| -44.30% | -13.45K |
$86.96 | -$1,169,264.16 | 16.9K |
Dec 9
| |||
Form 4
| -58.31% | -42.45K |
$90.10 | -$3,824,940.27 | 30.35K |
Nov 29
| |||
Form 4
| -19.31% | -17.42K |
$118.26 | -$2,059,852.68 | 72.8K |
Feb 28
| |||
Form 4
| +77.24% | 39.32K |
—
|
—
| 90.22K |
Feb 15
| |||
Form 4
| -21.85% | -14.23K |
$95.95 | -$1,365,848.25 | 50.9K |
Dec 9
| |||
Form 4
| -21.93% | -18.30K |
$90.55 | -$1,657,037.10 | 65.14K |
Oct 30
| |||
Form 4
| -0.18% | -300.00 |
$70.41 | -$21,127.00 | 167.07K |
Jul 31
| |||
Form 4
| -17.69% | -18.00K |
$70.09 | -$1,261,638.37 | 83.74K |
Jul 31
| |||
Form 4
| -16.89% | -20.67K |
$62.22 | -$1,286,274.06 | 101.74K |
Feb 28
| |||
Form 4
| +58.61% | 45.23K |
—
|
—
| 122.41K |
Feb 16
| |||
Form 4
| -15.23% | -13.87K |
$60.90 | -$844,743.90 | 77.18K |
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
|
∞
| 91.05K |
—
|
—
| 91.05K |
Dec 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Neumora Therapeutics, Inc. (NMRA) Snapshot price: $10.46
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +20.92% | 80K |
—
|
—
| 462.35K |
Feb 14
| |||
Form 4
|
∞
| 15K |
$12.62 | $189,370.50 | 15K |
Sep 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACELYRIN, Inc. (SLRN) Snapshot price: $4.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
∞
| 50K |
$18.00 | $900,000.00 | 50K |
May 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aptinyx Inc. (APTX) Snapshot price: $0.09
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
| +25.00% | 25K |
$3.00 | $75,000.00 | 125K |
Jan 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
| 100K |
Oct 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
∞
| 100K |
$3.86 | $385,623.80 | 100K |
May 7 - May 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||